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abstract 
background:  Dermatitis and acne account for a large number of general practitioner appointments 
yet are amenable to treatment with products available to purchase from community pharmacies. 
objectives:
1. The clinical appropriateness of community pharmacy interventions for these conditions 
2. Patient reported measures of the effectiveness of the pharmacist’s management of their condition.
Methods: Nine community pharmacies opportunistically recruited patients presenting with suspected 
cases of both conditions, taking digital images and audio-recording the consultation. These files were 
uploaded to a secure site and independently reviewed by three dermatology specialists. 
Following their consultation, patients received a questionnaire to assess their views on the effectiveness 
of the treatment provided and their level of satisfaction with pharmacy management. 
results: Forty patients (36 dermatitis and 4 acne) were recruited. 
Of 113 assessments (7 not rated due to missing data) reviewed, specialists agreed with pharmacist’s 
diagnosis in 33.6% of cases, disagreed in 38.9% but were unable to determine the diagnosis in 27% 
of cases. Treatment was deemed appropriate in 42% of cases, inappropriate in 27% and indeterminate 
in 31% of cases.
Twenty-three patients (58%) returned a questionnaire and 12 of these (54.5%, 1 missing) stated that 
their condition had cleared completely following pharmacist advised treatment. Almost all (91.3%) 
were very satisfied or satisfied with the advice and/or treatment provided. 
conclusion: Specialists judged the clinical appropriateness of pharmacist diagnosis and management 
as suboptimal yet patients were more positive. This study indicates a possible need for greater 
assessment-related training in dermatology for study pharmacists and further work to determine the 
generalisability of findings.
©SelFcAre 2017
1www.selfcarejournal.com
SelfCare 2017;8(2):1-10
r e v i e w
   Advancing the study&understanding of self-care
an exploratory study of coMMunity pharMacist 
diagnosis and ManageMent of derMatitis and acne 
rod p tucker*, katie Maclure*, vibhu paudyal*, alison M layton**, 
anthony bewley†, derek stewart*
*School of Pharmacy and life Sciences, robert Gordon University, Aberdeen, AB10 7GJ, Scotland, UK
**Harrogate & District NHS Foundation Trust, Department of Dermatology, Harrogate, england, UK
†Whipps cross University Hospital, Department of Dermatology, london, england, UK
key words: dermatology, primary care, case management, common illnesses, consultation
introduction 
Self-care is defined by the World Health Organisation as ‘what people do for themselves to establish 
and maintain health, prevent and deal with illness’1. Self-care signifies the importance of  patient 
‘autonomy’ and ‘independence’, in which people make their own decisions about care and initiate 
actions by themselves2. Recent concepts of  self-care also encompass shared models of  care3, 
highlighting the interplay between patient autonomy and support from healthcare professionals 
where necessary2. Self-care is a feature of  the patient-centred United Kingdom (UK) National 
Health Service (NHS), with the position of  community pharmacy articulated in government policy4. 
This position is reinforced by evidence of  community pharmacy support enhancing patient access 
and reducing NHS direct and indirect costs5.
Studies suggest that dermatological conditions such as dermatitis and acne account for 6.8 and 2.4 
million general practitioner (GP) appointments every year in the UK6,7, yet both are amenable, to 
some extent, to supported self-care with treatments purchased through community pharmacies. 
Moreover, some evidence suggests that community pharmacists perceive that patients frequently 
seek their advice on conditions such as eczema and dermatitis8. Patients with skin problems visit 
pharmacies for advice on their problem for several reasons including the potential for triage to GP 
care, the perceived minor nature of  the problem and locality or familiarity with the pharmacy9. 
Despite the potential role of  community pharmacists in the management of  skin problems, there 
is a dearth of  studies on the diagnosis, management and outcomes associated with pharmacy 
supported self-care of  those with dermatological conditions. One study reported on the use of  
digital photography of  skin conditions encountered by community pharmacists with feedback 
from a dermatologist on the accuracy of  the diagnosis, yielding moderate agreement between the 
pharmacists and the dermatologist (Kappa = 0.58)10. However, limitations of  that study included the 
use of  a single assessor and absence of  data on the content of  the pharmacist-patient consultation. 
The use of  community pharmacists as an alternative to the GP for the management of  dermatitis 
and acne raises two important issues. Firstly, it is unknown whether pharmacists able to undertake 
an appropriate assessment and offer suitable advice and/or treatment to patients who presented 
with suspected cases of  either condition. Secondly, there is a need to determine whether or not 
pharmacy-based management of  these conditions leads to a satisfactory resolution of  a patient’s 
symptoms and thereby avoids the need for further medical input. Such issues are relevant in the 
context of  both the potential transfer of  consultations from GPs and to the suitability of  pharmacy 
supported self-care for people with both conditions.
 The aims of  the present exploratory study were therefore to assess the clinical appropriateness 
of  pharmacist assessment and management of  dermatitis and acne as well as obtaining patients’ 
self-reported perceptions on the effectiveness of  and satisfaction with the pharmacy intervention.
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Materials and Methods
Study design and setting
This was a mixed method, exploratory study undertaken in nine community pharmacies in the 
South West and South of  England between July 2015 and April 2016.
Patients
Eligible patients were those presenting at one of  the participating pharmacies with symptoms 
suggestive to the pharmacist of  mild to moderate acne and mild to moderate dermatitis, including 
atopic, seborrheoic and both irritant and allergic contact dermatitis. 
Pharmacists
Prior to the study, all pharmacists undertook training in ‘research ready’ good clinical practice and 
were supplied with a pack that contained a digital camera (Sony DSCW430 20.1 megapixel 8 x 
optical zoom with 4Gb SDHC memory care); a digital audio voice recorder (aLLreLi CP0034 8Gb); 
a full (8 page) study guide which provided step-by-step instructions on how to use both devices and 
an aperture card to hold over the skin area to protect the participant’s identity. Both the camera 
and audio device were pre-set to optimise and regulate recording in the consultation environment. 
Consultation
The pharmacists explained the nature of  the study and gained signed informed consent prior 
to their consultation which took place in a private room within the pharmacy. The pharmacist 
audio-recorded the consultation and took digital, representative photographs of  the presenting skin 
problem. After completion of  the consultation, pharmacists uploaded the audio-recordings and 
digital images to a secure Cloud location.
Independent assessors
The anonymised pharmacy case identified audio and image files were shared by the research team 
with three pre-assigned dermatology specialists (two consultants and a GP with a special interest 
in dermatology) who each and independently completed an online form sharing their views on 
the assessment, diagnosis, treatment and advice provided. The assessments were recorded on a 
standardised, pre-defined binary option (yes/no) template which assessed whether pharmacists 
had addressed specific areas during the consultation e.g. duration of  symptoms, sites affected, 
medication use etc. The template also allowed space for free text for specialists to highlight the 
strengths and weaknesses of  the consultation. Finally, the specialists were asked to record if  they 
thought that the pharmacists identified correctly the skin condition and whether they felt the 
treatment provided was adequate (responses yes, no or unable to determine from the available 
information). 
Patient follow-up
All participants (parents for those < 16 years) were sent a questionnaire, via post or email, either 
approximately ten days (dermatitis) or six weeks (acne) after their pharmacy consultation. This 
follow-up questionnaire comprised closed (e.g. Likert-type scales) and open questions on self-
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reported clinical effectiveness, (e.g. resolution of  symptoms, any need for re-consultation or further 
intervention), acceptability and satisfaction with their care. The questionnaire was reviewed for 
face and content validity by relevant healthcare professionals and expert patients recruited from 
professional networks.
Outcome measures
The following outcome measures were reported:
1.  The clinical appropriateness of  the pharmacist diagnosis and management of  both conditions, 
defined as yes/no/unable to determine, as judged by the assessors.
2.  Patient self-reported effectiveness of  the treatment, defined as completely cleared (yes/no) and 
if  not completely resolved, determined using a 5-point Likert scale (much better to much worse)
3. Patient self-reported levels of  satisfaction with pharmacy-based management.
Statistical analysis
Data were analysed descriptively, with the level of  agreement between assessors measured by 
pairwise comparison of  Kappa values. Kappa below 0.4 were regarded as poor agreement, ≥ 0.4 
as moderate agreement and values ≥ 0.6 as good agreement11. Statistical analyses was performed 
using SPSS (IBM Corp Released 2012. IBM SPSS for Mac, Version 23.0. Armonk, NY: IBM Corp). 
Content analysis was used to analyse free text comments.
Results
Forty participants (36 dermatitis, 4 acne; 7 were < 16 years of  age) were recruited by nine 
pharmacies over a nine-month period July 2015 to April 2016. All sites recruited between one and 
nine participants, with a further 12 potential participants refusing to take part.
The three assessors each provided feedback on all 40 patients giving a total of  120 assessments. 
Figure 1 provides an overview of  the assessors’ feedback on pharmacist questioning of  participants; 
pharmacists asked largely appropriate questions in relation to duration of  the problem and where it 
started, while the effects of  smoking/alcohol and family history were seldom addressed.
figure 1: proportion of all consultations assessors judged that the pharmacists asked appropriate questions 
Description of lesion
Patient’s assessment of severity today
impact of the problem
Other medicines taken
concomitant medical conditions
Previous treatment used
Affected by smoking/alcohol intake
Family history/other members affected
Occupation/hobbies affecting the problem 
Affected by sunlight
Presence/absence of itch
Provoking/relieving factors
Previous episodes
Duration of the problem
Where the problem started
0                      10                      20                      30                      40                     50                      60                      70                     80           
% of cases where pharmacists questioned appropriately
proportion of consultations in which appropriate questions were asked (n=120)
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Three key themes emerged from content analysis of  the assessors’ comments in relation to 
pharmacists’ assessment which were: inadequate history taking, inadequate diagnostic questioning 
and positive diagnostic questioning. Illustrative quotes for each of  these themes are shown in 
Table 1.
table 1
theme
inadequate history 
taking
inadequate diagnostic 
questioning
positive diagnostic 
questioning
 illustrative comments  
•   Specific questions in the history that would have helped the 
diagnosis not secured
•   Very brief history taken, no enquiry that might have indicated 
underlying cause of the itching.
•   A more detailed history would have been helpful and may have 
supported making the diagnosis.
•   No diagnosis made before telling patient to use exactly what she 
has just used and it didn’t work!  Then touched on the correct 
diagnosis - fungal element - it came out in the history- not 
realised by pharmacist
•   This is varicose eczema and the patient gives a good history 
himself, the diagnosis was not recognised [by the pharmacist] and 
the varicose veins were not considered an issue -  which they are
•   Specific questions not asked which would have helped with the 
diagnosis, would have been useful to consider whether there 
were other sites affected
•   Asked a lot of good questions, let the patient speak which was 
good. Got the diagnosis right but got the treatment wrong!
•   Good history. I would have like to know if he was taking other 
medications and had other health problems.  correct diagnosis 
and correct treatment. i liked the way he checked the patient’s 
understanding and also used fingertip units to explain to the 
patient how to use topical steroids
•   Good history and correct diagnosis. Good explanation of how to 
use the creams, i liked the increased use of emollients - she clearly 
had not been using enough and i liked the repeating of the 
management advice to check she had got all the information.
Assessment of  pharmacist’s diagnosis and treatment supplied
Of  the 113 cases rated by the assessors (seven were not rated due to missing data), they agreed 
with the pharmacist’s diagnosis in just over one third (34%, 38/113) of  cases, while they disagreed 
with the diagnosis in 39% (44/113). They were unable to determine from listening to the audio 
and viewing the images whether or not the pharmacists made the correct diagnosis in over one 
quarter (27%) of  cases. When asked to state whether or not they were able to recognise the skin 
condition based on the available information, this was only possible in 60% (67/113) of  cases due 
a combination of  poor quality images and audio recording.
With respect to the treatment supplied, the assessors agreed that the treatment was appropriate 
in 42% (47/113) of  cases, but inappropriate in 27% (30/113) of  cases. A judgement could not be 
determined in 31% (35/113) of  cases.
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The level of  agreement between the three assessors was determined using pairwise Kappa values 
and the results in relation to pharmacist’s diagnosis and treatment are shown in Table 2. 
table 2
diagnosis
assessors
Assessor 1 vs 2
Assessor 1 vs 3
Assessor 2 vs 3
treatment
Assessor 1 vs 2
Assessor 1 vs 3
Assessor 2 vs 3
kappa values
0.304
0.235
0.225
0.254
0.026
0.115
p value
  0.040*
  0.029*
0.055
  0.020*
0.792
0.307
 
These data suggest a poor degree of  agreement and inspection of  the data for the pharmacist’s 
diagnosis as shown in Figure 2, illustrates this level of  disagreement.
figure 2: assessors’ responses to appropriateness of pharmacist diagnosis for the management of dermatitis 
and acne 
25
20
15
10
5
0
assessors agreement with pharmacists diagnosis
reviewer 1
yes         no         unable to determine
reviewer 2 reviewer 3
Patient follow-up questionnaire
Twenty-three patients (57.5%) returned a completed questionnaire. In relation to their skin 
condition, fourteen patients (60.9%) had endured their problem for more than two weeks before 
seeking advice at a pharmacy, seven (30.4%) had the problem for between one and two weeks while 
two patients (8.7%) had their problem for less than a week before seeking advice. 
The reasons for participants’ choice of  pharmacy for advice are shown in Figure 3 which suggests 
both convenience and not wanting to bother the GP over a skin problem were the most frequently 
cited reasons. 
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*significant values
figure 3: patient reported reasons for visiting a pharmacy for advice on their skin problem
Others recommended the pharmacy
Used pharmacy before with another problem & satisfied
Used pharmacy before with skin problem & satisfied
Visited pharmacy for another reason
Didn’t want to bother GP with skin problem
more convenient than going to the GP
0                   5                   10                 15                  20                  25                  30                  35                 40     
% responses
patient feedback (n=23)
After seeking advice at the pharmacy, a high majority of  the patients (81.8%, 18/22; one missing) 
received advice and a topical product. However, two patients provided with a topical product were 
also advised to see their GP, and a further two patients were referred directly to their GP. 
Just over half  (54.5%, 12/22; one missing) stated that their acne or dermatitis had cleared up 
completely following the use of  the treatment they received at the pharmacy; two reported that 
their condition was much better and nine moderately better. Only six patients (26.1%) had to 
subsequently visit a GP about their skin problem.
When asked, 52.2% (12/23) of  participants stated that they were ‘very satisfied’ with the advice and 
treatment they received at the pharmacy, 39.1% (9/23) were ‘satisfied’, but 8.7% (2/23) reported 
that they were ‘very dissatisfied’.
In terms of  future intentions, 78.3% (18/23) of  patients said they were ‘very likely’ to visit a 
community pharmacy if  they developed a skin problem, with 17.4% (4/23) stating ‘likely’ and one 
unsure.
Finally, the majority of  respondents,78.3% (18/23) were ‘very likely’ to suggest that a friend or 
colleague sought advice on a skin problem from a pharmacy. 
discussion
Key findings
According to the independent assessors, community pharmacists identified correctly a patients’ 
skin problem in just over a third of  cases and provided appropriate treatment in less than half  of  
all cases examined. In contrast and though limited by the small responding sample size, the results 
from the patient questionnaire found that 54.5% of  participants felt that their skin problem had 
completely cleared up with the treatment provided at the pharmacy. Though none of  the patients 
with acne reported that their condition had completely cleared, all reported that it was moderately 
better. Furthermore, levels of  patient satisfaction were high, with over 90% reporting that they were 
either ‘satisfied’ or ‘very satisfied’ with the advice and treatment they received. This high level of  
satisfaction may indicate that patients experiencing a resolution of  their problem attributed this to 
the advice and/or treatment offered at the pharmacy. It was also encouraging to note that, based 
on their pharmacy encounter, almost all patients reported being ‘very likely’ or ‘likely’ to visit a 
community pharmacy for advice on a skin condition in the future and to recommend that friends 
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or colleagues with a skin problem seek advice from a pharmacist. These findings are in agreement 
with the data obtained from patients in an Australian pharmacy-based study reported by Plunkett et 
al12, showing a mean satisfaction score of  6.25 on a seven-point scale after treatment for their skin 
condition in a community pharmacy. 
Though these patient data are subjective and potentially subject to recall and acquiescence bias, 
they indicate that patient perception of  successful assessment, diagnosis and management was 
more favourable than implied from the assessors’ rating. There could be a number of  reasons 
for this difference. It is highly likely that the assessors’ views of  appropriateness will be different 
to the views of  patients. Furthermore, patients’ skin conditions may well have resolved without 
appropriate treatment even in circumstances where the diagnosis was not exact and as noted 
earlier, the assessors were unable to rate the suitability of  treatment in over a quarter of  cases. 
Additionally, and equally important, was the observation that only six patients people needed to 
seek the advice of  a GP because their skin condition failed to resolve with treatment from the 
pharmacy. It may be that patient perspectives are not a valid measure of  appropriateness.
Strengths and limitations
This study has important strengths and some recognised limitations. A major strength has been the 
unique use of  a combination of  digital photography and audio recording which permitted capture 
of  both the content of  the consultation and an image of  the skin problem. Additionally, the use of  
a three-person panel of  independent specialists and a follow-up patient questionnaire has allowed 
an examination of  the clinical appropriateness of  pharmacist management complemented by the 
patient perspective. Together, these attributes have provided valuable insight into the management 
of  these conditions by community pharmacists. There are, however, several weaknesses, and the 
findings should be interpreted with caution. This was an exploratory study hence the number of  
pharmacists and patients was low (especially those with acne), and skin conditions examined were 
limited to dermatitis and acne. Furthermore, this exploratory study did not intend to generate 
findings which could be generalised to the wider population. The lack of  agreement or consistency 
between assessors and the patient questionnaire response rate of  just over 50% has implications 
for response bias and generalising the follow-up findings to all study patients. Finally, the follow-up 
data was from the patient perspective only, without independent verification.
Implications for practice
UK government health policy has for many years, advocated an important role for community 
pharmacists in providing access to NHS treatment, professional advice and onward referral where 
appropriate, through the provision of  minor ailment schemes13. Indeed, research suggests that 
as many as 20% of  GP consultations are for minor ailments7, and for many patients this is both 
inconvenient and an inefficient use of  their time, especially given that some evidence points 
towards a preference for self-care among those with minor illness14. Moreover, a recent systematic 
review of  pharmacy-based minor ailment schemes, found that the proportion of  patients reporting 
complete resolution of  symptoms after a minor ailment consultation ranged from 68 to 94%5. A 
further study that focused on four minor ailments managed by pharmacies, general practitioners 
and emergency departments found a similar degree of  symptom resolution across all four settings 
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but that pharmacy consultations were associated with the lowest costs15. Fundamental to these 
studies is an implicit assumption, that pharmacists possess the necessary skills and knowledge 
to undertake an appropriate assessment of  patients who present with minor ailments. However, 
studies specifically exploring the questioning and assessment of  patients by pharmacists have 
revealed considerable variation16-18. The current study provides further evidence of  pharmacists’ 
suboptimal assessment of  patients. Nonetheless, an important caveat in the present study was the 
inability of  assessors to determine the appropriateness of  pharmacists’ assessment in around a 
quarter of  cases, which may simply reflect pharmacists’ failure to articulate a diagnosis during the 
consultation rather than suboptimal appraisal of  the presenting problem. 
There is clearly a need for further studies using larger pharmacist and patient cohorts or perhaps 
using GPs are a comparator group, to explore the generalizability of  these finding to the wider 
pharmacist and patient population. It would also seem prudent to explore the impact of  additional 
dermatology related education for pharmacists especially in relation to patient assessment as other 
work suggests that pharmacists’ diagnostic ability with respect to skin problems is inferior to GPs19. 
conclusion
This study has identified that, according to expert assessors, the study pharmacists’ assessment, 
diagnosis and management of  dermatitis and acne were deemed appropriate in only about a third 
of  cases. The lack of  appropriate questioning prior to diagnosis was viewed by the assessors as 
a key weakness. Patient feedback was much more positive, revealing a high level of  satisfaction 
with community pharmacist management. There appears to be a need for further dermatological 
education and training for the study pharmacists and future studies should focus on a determination 
of  the generalizability of  these findings.
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